Literature DB >> 20887713

Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2.

Shin-Ichi Yokota1, Eriko Higashi, Tatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima.   

Abstract

Human CYP2A6 is responsible for the metabolism of nicotine and coumarin as well as the metabolic activation of tobacco-related nitrosamines. Earlier studies revealed that CYP2A6 activity was increased by dietary cadmium or cruciferous vegetables, but the underlying mechanisms remain to be clarified. In the present study, we investigated the possibility that Nrf2 might be involved in the regulation of CYP2A6. Real-time RT-PCR analysis revealed that the CYP2A6 mRNA level in human hepatocytes was significantly (P<0.01, 1.4-fold) induced by 10μM sulforaphane (SFN), a typical activator of Nrf2. A computer-based search identified three putative antioxidant response elements (AREs) in the 5'-flanking region of the CYP2A6 gene at positions -1212, -2444, and -3441, termed ARE1, ARE2, and ARE3, respectively. Electrophoretic mobility shift assays demonstrated that Nrf2 bound only to ARE1. Luciferase assays using HepG2 cells revealed that the overexpression of Nrf2 significantly increased the reporter activities of the constructs containing a 30-bp fragment that included ARE1. However, the activity of the construct containing the intact 5'-flanking region (-1 to -1395) including ARE1 was not increased by the overexpression of Nrf2. In contrast, when the reporter construct was injected into mice via the tail vein, the reporter activity in the liver was significantly (P<0.05, 1.9-fold) increased by SFN (1mg/head) administration. In conclusion, we found that human CYP2A6 is regulated via Nrf2, suggesting that CYP2A6 is induced under oxidative stress. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887713     DOI: 10.1016/j.bcp.2010.09.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

Review 1.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2.

Authors:  Qiuying Cheng; James L Kalabus; Jianping Zhang; Javier G Blanco
Journal:  Biochem Pharmacol       Date:  2011-10-05       Impact factor: 5.858

3.  A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.

Authors:  Mengyao Jin; Ravinder Earla; Ankit Shah; Rajya L Earla; Raeesa Gupte; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-08       Impact factor: 4.147

4.  Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.

Authors:  Xue Chen; Stephen C Ward; Arthur I Cederbaum; Huabao Xiong; Yongke Lu
Journal:  Toxicology       Date:  2017-01-25       Impact factor: 4.221

5.  Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.

Authors:  Yongke Lu; Xu Hannah Zhang; Arthur I Cederbaum
Journal:  Toxicol Sci       Date:  2012-05-02       Impact factor: 4.849

6.  Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.

Authors:  Feng Hong; Xiyu Liu; Stephen S Ward; Huabao Xiong; Arthur I Cederbaum; Yongke Lu
Journal:  Dig Liver Dis       Date:  2015-03-06       Impact factor: 4.088

7.  Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  React Oxyg Species (Apex)       Date:  2016-03

8.  Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells.

Authors:  M A Siddiqui; J Ahmad; N N Farshori; Q Saquib; S Jahan; M P Kashyap; M Ahamed; J Musarrat; A A Al-Khedhairy
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

9.  The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.

Authors:  Feng Hong; Chuanping Si; Pengfei Gao; Arthur I Cederbaum; Huabao Xiong; Yongke Lu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-09-12       Impact factor: 3.000

Review 10.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.